Genetic Variation of Ultra-Potent Synthetic Opioid Sensitivity in Mice
小鼠超强合成阿片类药物敏感性的遗传变异
基本信息
- 批准号:10743432
- 负责人:
- 金额:$ 45.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAffectAfrican American populationApneaAutomobile DrivingBiologicalBloodBlood gasBrain StemCandidate Disease GeneCarbon DioxideCardiovascular systemCationsCause of DeathCellsCentral Nervous SystemCessation of lifeChest wall structureClustered Regularly Interspaced Short Palindromic RepeatsCoupledDataDevelopmentDoseEpidemicExhibitsFentanylFoundationsGene ExpressionGenesGeneticGenetic VariationGenetic studyGenotypeGoalsHumanInbred Strains MiceIndividual DifferencesKnock-outLethal Dose 50LungMeasuresMolecularMonitorMorphineMoscowMouse StrainsMusNaloxoneOpioidOpioid AnalgesicsOpioid AntagonistOpioid ReceptorOverdoseOxygenPathway interactionsPatientsPeripheral Nervous SystemPhenotypePhysiologicalPlethysmographyPopulationRecoveryRespiratory MechanicsSignal TransductionStreet DrugsTestingTherapeuticTidal VolumeTimeTissue-Specific Gene ExpressionToxic effectToxicokineticsVariantVentilatory DepressionWithdrawalWooden Chest SyndromeWorkaddictionaerosolizedanalogbehavioral phenotypingcarfentanilcell typecohortdetection platformdifferential expressionelectric impedancegenome wide association studyhemodynamicsindividual variationinnovationinsightmolecular phenotypeneuralnovelopioid overdoseoverdose deathoverdose riskpreBotzinger complexprescription opioidpsychologicrespiratoryresponsesegregationsexsingle nucleus RNA-sequencingsynthetic opioidtargeted treatmenttherapeutic developmenttranslational impactventilationweapons
项目摘要
PROJECT SUMMARY/ABSTRACT
The weaponization of Ultrapotent synthetic opioids (UPS) has made finding a novel reversal agent a priority. The
current opioid response agent, Naloxone, is not as effective against UPS opioids and does not reverse one of
its known effects, wooden chest syndrome. Our long-term goal is to define the biological basis of opioid
overdose risk and promote the discovery of safe and effective agents that reverse fentanyl lethality. A key
objective is determining the molecular mechanisms underlying individual variability to fentanyl toxicity using
genetically diverse mice. In aim 1 we plan to identify genes and variants that modify the influence of Mcoln1 on
acute UPS opioid toxicity. Mcoln1 was identified in a GWAS study of overdose risk, and preliminary data support
a genetic knockout of Mcoln1 resulting in death more rapidly from morphine or fentanyl. We will create an
additional CRISPR knockout of Mcoln1 on a more sensitive genetic background, NOD/ShiLtJ and compare it
with the C57BL/6 knockout we have for response to the UPS opioid fentanyl. The LD50 will be determined for
these strains using our piezoelectric respiratory depression detection system. We will also study respiratory
mechanics and pulmonary and chest wall impedance in response to three doses of fentanyl. In another cohort
of mice, they will be tested by plethysmography to acquire respiratory metrics such as tidal volume and minute
ventilation. We will also collect arterial blood to measure blood gases of oxygen and carbon dioxide during the
plethysmography session to monitor the response to fentanyl at that level. Finally, another cohort of naïve and
fentanyl-treated mice will be dissected for brain stems. The pre-bötzinger complex will be identified and analyzed
by single-nucleus RNA-Seq, comparing the cellular populations and differential gene expression across
genotypes, sexes and treatments. In aim 2 we plan to identify the physiological, neural, and molecular
mechanisms of variable fentanyl-induced toxicity and lethality among eight inbred mouse strains. These eight
strains, which served as the foundation for the advanced mouse populations of the Collaborative Cross and
Diversity Outbred mice, contain approximately 45 million SNPs segregating between them. We have determined
that the LD50 for fentanyl varies > 150-fold across both sexes of the eight strains. As in aim 1, in aim 2 we will
phenotype cohorts of mice to detect the diverse phenomena associated with UPS opioids, including Opioid-
Induced Respiratory Depression (OIRD), Opioid-Induced Persistent Apnea (OIPA), Wooden Chest Syndrome
(WCS), closure/collapse of the upper and cardiovascular/hemodynamic disturbances. This phenotyping will be
coupled to identifying the cellular populations, through single nucleus RNA-Seq, within the brainstem pre-
bötzinger region that varies across naïve and fentanyl-treated strains of both sexes of mice. The differentially
expressed genes that define these populations will help us identify targets for therapeutic development
associated with the different fentanyl lethality phenotypes.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason A Bubier其他文献
Jason A Bubier的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason A Bubier', 18)}}的其他基金
Genetic Variation in Opioid Induced Respiratory Depression in Mice
阿片类药物引起的小鼠呼吸抑制的遗传变异
- 批准号:
10554309 - 财政年份:2020
- 资助金额:
$ 45.61万 - 项目类别:
Genetic Variation in Opioid Induced Respiratory Depression in Mice
阿片类药物引起的小鼠呼吸抑制的遗传变异
- 批准号:
10347353 - 财政年份:2020
- 资助金额:
$ 45.61万 - 项目类别:
Genetic Control of Addiction by Host and Microbiome
宿主和微生物组对成瘾的遗传控制
- 批准号:
10218130 - 财政年份:2018
- 资助金额:
$ 45.61万 - 项目类别:
Genetic Control of Addiction by Host and Microbiome
宿主和微生物组对成瘾的遗传控制
- 批准号:
10452640 - 财政年份:2018
- 资助金额:
$ 45.61万 - 项目类别:
Genetic Control of Addiction by Host and Microbiome
宿主和微生物组对成瘾的遗传控制
- 批准号:
9789240 - 财政年份:2018
- 资助金额:
$ 45.61万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 45.61万 - 项目类别:
Research Grant